Investigation of Remimazolam in Children Undergoing Sedation for Medical Procedures
Status:
Not yet recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
To assess the efficacy of intravenous remimazolam in inducing and maintaining suitable
sedation levels for paediatric patients undergoing diagnostic and/or therapeutic procedures